1. Home
  2. RELI vs JAGX Comparison

RELI vs JAGX Comparison

Compare RELI & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reliance Global Group Inc.

RELI

Reliance Global Group Inc.

HOLD

Current Price

$0.63

Market Cap

6.5M

Sector

Finance

ML Signal

HOLD

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$1.19

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RELI
JAGX
Founded
2013
2013
Country
United States
United States
Employees
64
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
3.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RELI
JAGX
Price
$0.63
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$60.00
AVG Volume (30 Days)
2.1M
380.3K
Earning Date
11-06-2025
11-17-2025
Dividend Yield
4.53%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,115,995.00
$11,785,000.00
Revenue This Year
N/A
$22.41
Revenue Next Year
N/A
$30.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.45
52 Week Low
$0.61
$1.00
52 Week High
$5.11
$33.25

Technical Indicators

Market Signals
Indicator
RELI
JAGX
Relative Strength Index (RSI) 36.84 41.39
Support Level $0.68 $1.05
Resistance Level $0.83 $1.36
Average True Range (ATR) 0.06 0.16
MACD 0.00 0.04
Stochastic Oscillator 2.57 38.00

Price Performance

Historical Comparison
RELI
JAGX

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: